Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies

Review: Therapeutic advances and future prospects in immune-mediated inflammatory myopathies

The inflammatory myopathies include three distinct entities: polymyositis (PM), dermatomyositis (DM), and inclusion body myositis (IBM). A T-cell-mediated cytotoxic process in PM and IBM and a complement-mediated microangiopathy in DM are the hallmarks of the underlying autoimmune processes. The mos...

Full description

Bibliographic Details
Main Author:	Marinos C. Dalakas
Format:	Article
Language:	English
Published:	SAGE Publishing 2008-11-01
Series:	Therapeutic Advances in Neurological Disorders
Online Access:	https://doi.org/10.1177/1756285608097463

Similar Items

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
by: Marinos C. Dalakas
Published: (2018-01-01)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
by: Marinos C. Dalakas
Published: (2018-09-01)

Future perspectives in target-specific immunotherapies of myasthenia gravis
by: Marinos C. Dalakas
Published: (2015-11-01)

The advance of idiopathic inflammatory myopathy
by: Yun YUAN
Published: (2016-10-01)

Emerging therapeutics in idiopathic inflammatory myopathy
by: Shinji Sato
Published: (2020-01-01)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
by: Marinos C. Dalakas, et al.
Published: (2021-02-01)

Autophagy, inflammation and innate immunity in inflammatory myopathies.
by: Cristina Cappelletti, et al.
Published: (2014-01-01)

Statins and Immune-Mediated Necrotizing Myopathy
by: Mauro Turrin
Published: (2018-10-01)

Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study
by: Dorward Heidi, et al.
Published: (2007-01-01)

Therapeutic advances in the management of Pompe disease and other metabolic myopathies
by: Corrado Angelini, et al.
Published: (2013-09-01)

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
by: Popianna Tsiortou, et al.
Published: (2021-03-01)

Immune-Mediated Necrotizing Myopathy: An Often Misdiagnosed Entity
by: Joana Almeida Espírito Santo, et al.
Published: (2015-01-01)

Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies
by: Boel De Paepe, et al.
Published: (2015-08-01)

Congenital Inflammatory Myopathy
by: J Gordon Millichap
Published: (1990-07-01)

Inflammatory myopathies in the elderly
by: Edgard Torres dos Reis Neto, et al.
Published: (2008-03-01)

Gene therapy for Duchenne muscular dystrophy: balancing good science, marginal efficacy, high emotions and excessive cost
by: Marinos C. Dalakas
Published: (2017-08-01)

Acute Hemorrhagic Myositis in Inflammatory Myopathy and Review of the Literature
by: Howard Van Gelder, et al.
Published: (2014-01-01)

Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum
by: Ying S, et al.
Published: (2020-08-01)

Idiopathic Inflammatory Myopathies Recent Developments
Published: (2011)

Idiopathic inflammatory myopathies and the lung
by: Jean-Christophe Lega, et al.
Published: (2015-06-01)

Current essentials in inflammatory myopathies
by: Maren Breithaupt, et al.
Published: (2013-08-01)

Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies
by: Noman Ahmed Jang Khan MD, et al.
Published: (2017-06-01)

Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series
by: Anji Xiong, et al.
Published: (2021-03-01)

Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies
by: Vlad Mageriu, et al.
Published: (2020-01-01)

Idiopathic Inflammatory Myopathies: A Review of the Classification and Impact of Pathogenesis
by: Dana E. Mandel, et al.
Published: (2017-05-01)

Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer
by: Audrey Aussy, et al.
Published: (2017-08-01)

METABOLIC VS INFLAMMATORY MYOPATHY: DIAGNOSTIC DIFFICULTIES AND ERRORS IN MYOPATHIES – CASE REPORT
by: Andra-Patricia Stanciu, et al.
Published: (2019-09-01)

Biomarkers in Inflammatory Myopathies—An Expanded Definition
by: Olivier Benveniste, et al.
Published: (2019-06-01)

Gene Expression Profiles of Inflammatory Myopathies
by: J Gordon Millichap
Published: (2002-11-01)

History of diagnosis on idiopathic inflammatory myopathy
by: Wei ZHANG
Published: (2016-10-01)

Antiangiogenic VEGF Isoform in Inflammatory Myopathies
by: Nila Volpi, et al.
Published: (2013-01-01)

DISABILITY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
by: Natalia LOGHIN-OPREA, et al.
Published: (2019-03-01)

Vitamin D Receptor Agonists: Suitable Candidates as Novel Therapeutic Options in Autoimmune Inflammatory Myopathy
by: Clara Crescioli
Published: (2014-01-01)

The Clinicopathological Distinction Between Seropositive and Seronegative Immune-Mediated Necrotizing Myopathy in China
by: Xue Ma, et al.
Published: (2021-07-01)

A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies
by: Alexander Oldroyd, et al.
Published: (2019-10-01)

A review of accelerometer-derived physical activity in the idiopathic inflammatory myopathies
by: Oldroyd, Alexander, et al.
Published: (2020)

Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
by: Yan Jiang, et al.
Published: (2021-03-01)

Review: Colchicine, current advances and future prospects
by: MAHENDRA KUMAR RAI, et al.
Published: (2010-07-01)

Advances in quantitative MRI of hereditary myopathies
by: LIANG Ying⁃yin, et al.
Published: (2021-06-01)

What is new in idiopathic inflammatory myopathies: Mechanisms and therapies
by: Satish V Khadilkar, et al.
Published: (2020-01-01)

Cannot write session to /tmp/vufind_sessions/sess_dep3a18jcaj0tn2b2bt9ve6ad8